Literature DB >> 27100864

Regulation of Memory T Cells by Interleukin-23.

Yanchun Li1, Hongbo Wang, Honghua Lu, Shucheng Hua.   

Abstract

Interleukin-23 (IL-23), a member of the IL-12 family of cytokines, is a heterodimeric cytokine. It is composed of subunits p40 (shared with IL-12) and p19 (an IL-12 p35-related subunit) and is secreted by several types of immune cells, such as natural killer cells and dendritic cells. The IL-23 receptor is composed of the subunit IL-12Rβ1 and the IL-23-specific subunit IL-23R. The binding of IL-23 to its specific cell surface receptor regulates a number of functions, including proliferation and differentiation of cells and secretion of cell factors. Memory T cells are a subset of T cells that secrete numerous important cell factors, and they function in the immune response to infection and diseases like cancer, autoimmune disease and bronchial asthma. IL-23R is expressed on the surface of memory T cells, which suggests that it can specifically regulate memory T cell function. IL-23 has been widely used as a clinical indicator in immune-related diseases and shows potential for use in disease treatment. Here we review the current progress in the study of the role of IL-23 in the regulation of memory T cells.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27100864     DOI: 10.1159/000445834

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  8 in total

1.  Gender affects IL-23 serum levels in the hospitalized COVID-19 infected patients.

Authors:  Mitra Abbasifard; Mohammad Kazemi Arababadi; Fatemeh Bahrehmand; Gholamreza Bazmandegan; Ziba Shabani Shahrbabaki; Zahra Kamiab
Journal:  Am J Clin Exp Immunol       Date:  2022-04-15

Review 2.  TTP-mediated regulation of mRNA stability in immune cells contributes to adaptive immunity, immune tolerance and clinical applications.

Authors:  Yiwei Zhang; Jian Zhou; Zhiyuan Wei; Hui Dong; Di Yang; Yuanyu Deng; Jiahui Li; Saiyu Shi; Yi Sun; Huimin Lu; Jizhao Yuan; Bing Ni; Yuzhang Wu; Yi Tian; Chao Han
Journal:  RNA Biol       Date:  2021-04-27       Impact factor: 4.652

3.  Androgen receptor activation alleviates airway hyperresponsiveness, inflammation, and remodeling in a murine model of asthma.

Authors:  Rama Satyanarayana Raju Kalidhindi; Nilesh Sudhakar Ambhore; Premanand Balraj; Taylor Schmidt; M Nadeem Khan; Venkatachalem Sathish
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-03-10       Impact factor: 5.464

4.  Aberrant expression of interleukin-23-regulated miRNAs in T cells from patients with ankylosing spondylitis.

Authors:  Ning-Sheng Lai; Hui-Chun Yu; Chien-Hsueh Tung; Kuang-Yung Huang; Hsien-Bin Huang; Ming-Chi Lu
Journal:  Arthritis Res Ther       Date:  2018-11-21       Impact factor: 5.156

Review 5.  Gene modification strategies for next-generation CAR T cells against solid cancers.

Authors:  Yonggui Tian; Yilu Li; Yupei Shao; Yi Zhang
Journal:  J Hematol Oncol       Date:  2020-05-18       Impact factor: 17.388

6.  Decidual memory T-cell subsets and memory T-cell stimulatory cytokines in early- and late-onset preeclampsia.

Authors:  Tom E C Kieffer; Anne Laskewitz; Annegé Vledder; Sicco A Scherjon; Marijke M Faas; Jelmer R Prins
Journal:  Am J Reprod Immunol       Date:  2020-07-08       Impact factor: 3.886

7.  Suckling by Schistosoma mansoni-infected mothers restored IgG2a and TGF-β production, but not IL-6 and delayed-type hypersensitivity in IL-12/IL-23-deficient mice.

Authors:  Fabiana Leticia da Silva; Maria da Conceição Silva; Gabriela Calixto Ribeiro de Holanda; Eridan de Medeiros Coutinho; Silvia Maria Lucena Montenegro; Clarice Neuenschwander Lins de Morais; Valdênia Maria Oliveira de Souza
Journal:  Rev Soc Bras Med Trop       Date:  2021-03-22       Impact factor: 1.581

Review 8.  The regulatory mechanism and potential application of IL-23 in autoimmune diseases.

Authors:  De-Kai Xiong; Xiang Shi; Miao-Miao Han; Xing-Min Zhang; Na-Na Wu; Xiu-Yue Sheng; Ji-Nian Wang
Journal:  Front Pharmacol       Date:  2022-09-13       Impact factor: 5.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.